Danielle Sloane helps national life science and healthcare clients navigate the complex maze of federal and state healthcare laws and regulations. With an analytical eye, Danielle helps her clients mitigate legal risk and achieve regulatory compliance consistent with their business goals. Working with clients ranging from hospitals and ambulatory surgical centers to medical device companies and laboratories, Danielle's practice involves:
- Compliance, Regulatory and Operational Matters – Analysis and counseling on the various federal and state regulatory requirements and operational impacts in connection with day-to day operations of health care providers and suppliers; guidance on general operational and compliance inquiries, including fraud and abuse, self-disclosure, licensure, Medicare/Medicaid certification, and other regulatory matters; Medicare contractor audits and appeals.
- Mergers, Acquisitions & Joint Ventures – Assisting with the buying and selling of hospitals, surgery centers, labs and other types of providers; advises on the structuring of syndications, joint ventures, physician integration models and strategic investment opportunities; conducts due diligence and analysis of healthcare joint ventures, mergers and acquisitions, including assisting with analysis of overpayments, repayments and self-disclosures necessary in connection with transactions.
- Government Investigations – Advises upon internal investigations and responding to governmental inquiries conducted by the Office of Inspector General, United States Department of Justice, Centers for Medicare/Medicaid and state regulatory agencies regarding potential regulatory, compliance and clinical issues.
Danielle advises clients on growth strategies by determining how they can best innovate, evolve and improve patient care within the confines of current healthcare regulatory laws. In addition, she works closely with corporate attorneys related to negotiating sales transaction documents or diligence on a prospective healthcare entity. She also provides valuable healthcare regulatory analysis as a team member of the firm's healthcare investigations group.